Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Pushing For Cosmetics Industry Cooperation On Allergens, Other Priorities

May 14 2021

• By Lauren Nardella

FDA building.

Related Content

US FDA Addresses PFAS In Cosmetics, Aiming To Close Data Gaps

Mar 09 2021

FDA Final Report: Asbestos Detected In 17% Of Talc-Containing Cosmetics, Including Products Previously Under Suspicion

Mar 10 2020

FDA Contracts For QRA Model To Determine Safe Use Levels For 26 Fragrance Allergens

Aug 25 2018

CIR Expert Panel Tentatively OKs Silicate Ingredients With Crystalline Caveats; Full Meeting Results

Mar 24 2021

US Rep. Pallone Demands Answers From FDA On Seeming Hair-Smoothing Formaldehyde Ban ‘Reversal’

Oct 27 2020

FDA Clarification: Interagency Recommendations On Talc-Asbestos Test Methods Not Formal Guidance

Aug 19 2020

US FDA’s Cosmetics Director Katz Cites Fragrance Allergens, Talc-Containing Products Among Priorities

Oct 07 2020

Additional Topics

United States FDA Safety Regulation Cosmetics Ingredients Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.